Using Large-area Low-level Light Therapy for Treating Adhesive Capsulitis of the Shoulder
1 other identifier
interventional
50
1 country
1
Brief Summary
Adhesive capsulitis, is a common problem characterized by the insidious onset of glenohumeral pain and limitation of shoulder motion in all planes. Clinically, frozen shoulder could be divided into freezing, frozen and thawing stage. The treatments of frozen shoulder are mainly conservative, including non-steroidal anti-inflammatory medications and physiotherapy. Due to debilitating pain at a certain stage and protracted clinical course, intra-articular corticosteroid injection in the early stages of idiopathic adhesive capsulitis has long been used to treat adhesive capsulitis with satisfactory result. However, intra-articular steroid injection still raise some controversy and is still considered too invasive for some patients. Low-level laser therapy (LLLT) is a safe and non-invasive alternative. LLLT can employ photo-biomodulation effects to help normalize cellular functions and is considered to have partial effect in many shoulder soft tissue disorders. Possible mechanisms include increasing adenosine triphosphate production, fibroblast activity and collagen synthesis. One prospective cohort study has shown that LLLT can be effective in the management of the early phase (less than 6 weeks of disease onset) of adhesive capsulitis of the shoulder in elderly who failed to respond to conventional physical therapy and nonsteroidal anti-inflammatory medications and improvement was found maintained up to 2 years. To this date, no randomized controlled study has been made to establish the possible role of LLLT as an adjuvant therapy on adhesive capsulitis. Also, no study has researched the effect of LLLT on patient with later stage/chronic phase of adhesive capsulitis. The objective of this paper is to report the clinical result of a study on the efficacy of LLLT as an add-on therapy in the management of adhesive capsulitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2023
CompletedStudy Start
First participant enrolled
July 21, 2023
CompletedFirst Posted
Study publicly available on registry
August 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedOctober 31, 2023
November 1, 2022
1.4 years
July 16, 2023
October 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Shoulder range of motion
Shoulder flexion, abduction, external rotation, internal rotation
24 weeks after enrollment
Shoulder pain score
Visual analogue scale for pain during shoulder motion (scale from 0 to 10, with higher scores mean worse outcome)
24 weeks after enrollment
Secondary Outcomes (3)
Functional evaluation
Immediate upon enrollment, and 8, 12, 24 weeks after enrollment
Ultrasound examination
Immediate upon enrollment, and 8, 12, 24 weeks after enrollment
Functional evaluation
Immediate upon enrollment, and 8, 12, 24 weeks after enrollment
Study Arms (2)
Treatment group (low-level laser therapy with conventional physical therapy)
EXPERIMENTALLow-level laser therapy two to three times a week, 10 minutes each time, totally 24 times, for 8 to 10 weeks. Along with conventional physical therapy, two to three times a week, for 12 to 14 weeks.
Conventional group (conventional physical therapy only)
ACTIVE COMPARATORConventional physical therapy, two to three times a week, for 12 to 14 weeks.
Interventions
Low-level laser therapy (LLLT), three time each week, 10 minutes each time, during the first 8 weeks of the treatment trial.
Conventional physical therapy will be applied three time each week, for 12 weeks
Eligibility Criteria
You may qualify if:
- Age between 40 to 85 years old
- Diagnosed with adhesive capsulitis clinically. Painful restriction of both active and passive flexion less than 120° and 50% restriction of the external rotation aside the body
- Visual analog scale of shoulder motion pain greater than 3 on a scale of 10
- No fracture, dislocation, or arthritis in shoulder region
You may not qualify if:
- History of or scheduled shoulder or chest surgery
- Significant shoulder trauma within the previous 2 years
- Presence of cervical radiculopathy or other central or peripheral neurologic deficits of the upper limb
- Known shoulder tendon tear or active tendinitis or bursitis as confirmed with US
- Contraindication of low-level light therapy
- Pregnancy, cancer, patient with pacemaker, high bleeding tendency, or longterm corticosteroid use.
- Poor consciousness state, or patients with sensory impairment
- Patients hypersensitive to light
- Severe circulatory system disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2023
First Posted
August 22, 2023
Study Start
July 21, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
October 31, 2023
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share